Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

CARM holding history

Carisma Therapeutics Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CARM overviewAll 13F holders of CARMFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of CARM by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−250,495−100.0%Sold outHolders
Q3 2025250,495$68.7K<0.1%00.0%UnchangedHolders
Q2 2025250,495$98.1K<0.1%+6,154+2.5%AddedHolders
Q1 2025244,341$75.8K<0.1%−14,843−5.7%ReducedHolders
Q4 2024259,184$108.6K<0.1%00.0%UnchangedHolders
Q3 2024259,184$254.5K<0.1%−24,224−8.5%ReducedHolders
Q2 2024283,408$430.9K<0.1%−245,181−46.4%ReducedHolders
Q1 2024528,589$1.20M<0.1%+12,696+2.5%AddedHolders
Q4 2023515,893$1.51M<0.1%+12,107+2.4%AddedHolders
Q3 2023503,786$2.13M<0.1%−36,210−6.7%ReducedHolders
Q2 2023539,996$4.74M<0.1%+421,293+354.9%AddedHolders
Q1 2023118,703$368.0K<0.1%+3,956+3.4%AddedConverted for a 1-for-20 splitHolders
Q4 20222,294,948$1.40M<0.1%+11,138+0.5%AddedHolders
Q3 20222,283,810$970.0K<0.1%−45,825−2.0%ReducedHolders
Q2 20222,329,635$1.89M<0.1%−1,891,643−44.8%ReducedHolders
Q1 20224,221,278$2.54M<0.1%−290,483−6.4%ReducedHolders
Q4 20214,511,761$3.68M<0.1%+1,890,771+72.1%AddedHolders
Q3 20212,620,990$2.08M<0.1%−229,571−8.1%ReducedHolders
Q2 20212,850,561$13.2M<0.1%+1,546,900+118.7%AddedHolders
Q1 20211,303,661$3.39M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.